id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-5962-0002,FDA,FDA-2024-E-5962,Patent Extension Application from Covington & Burling LLP (on behalf of Genzyme Corp.),Other,Application,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T18:00:02Z,,0,0,090000648689495f
FDA-2024-E-5962-0001,FDA,FDA-2024-E-5962,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T17:59:35Z,,0,0,090000648689495e